Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3240 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.81 USD | +0.63% | +11.09% | +34.36% | +278.74% | 342.41 M USD | ||
| 3250 |  OABI OmniAb, Inc. - Common Stock | 2.34 USD | +0.86% | -3.70% | +1.30% | +11.96% | 339.24 M USD | ||
| 3251 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.91 USD | -3.64% | -2.02% | +50.78% | +162.16% | 339.19 M USD | ||
| 3262 |  IRD Opus Genetics, Inc. - Common Stock | 4.08 USD | +0.74% | -1.45% | +0.49% | +9.68% | 332.09 M USD | ||
| 3272 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.32 USD | 0.00% | +0.76% | +9.09% | -23.26% | 329.07 M USD | ||
| 3305 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.35 USD | -0.42% | +13.53% | +48.73% | +422.22% | 316.22 M USD | ||
| 3329 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.99 USD | +1.53% | +1.27% | +10.22% | +15.32% | 307.98 M USD | ||
| 3330 |  HELP Cybin Inc. - Common Stock | 5.96 USD | -1.16% | -7.31% | +47.16% | -33.56% | 307.73 M USD | ||
| 3343 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.65 USD | -4.62% | +2.48% | 0.00% | +83.33% | 305.72 M USD | ||
| 3351 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | -0.22% | +5.02% | +90.08% | +113.95% | 302.94 M USD | ||
| 3370 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.88 USD | -0.51% | +1.84% | +14.12% | +57.72% | 296.68 M USD | ||
| 3381 |  MGNX MacroGenics, Inc. - Common Stock | 4.63 USD | -2.53% | +1.31% | +18.11% | +210.74% | 294.30 M USD | ||
| 3387 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.96 USD | -0.90% | -1.87% | +42.08% | +8.73% | 292.64 M USD | ||
| 3388 |  FBRX Forte Biosciences, Inc. - Common Stock | 21.07 USD | -5.30% | -0.14% | +33.44% | -28.21% | 292.57 M USD | ||
| 3392 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.49 USD | +0.54% | +0.54% | +17.21% | +7.46% | 290.77 M USD | ||
| 3423 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.30 USD | -4.22% | +33.05% | +82.35% | -7.00% | 277.03 M USD | ||
| 3432 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.42 USD | -9.36% | -17.97% | -9.02% | +27.37% | 274.05 M USD | ||
| 3438 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.41 USD | -1.16% | +2.71% | +1.19% | -31.53% | 271.59 M USD | ||
| 3442 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.02 USD | -1.46% | +2.02% | +22.42% | -0.98% | 266.71 M USD | ||
| 3443 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.16 USD | -2.21% | -21.42% | -18.53% | +79.98% | 266.56 M USD |
Noticias Biotechnology Stocks
TD Cowen reitera su recomendación de compra en Prime Medicine tras ganar arbitraje
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |